Nyxthracis (previously Obiltoxaximab SFL) Európska únia - slovenčina - EMA (European Medicines Agency)

nyxthracis (previously obiltoxaximab sfl)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - imunitný séra a imunoglobulíny, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.

Sativex orálny roztokový sprej Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sativex orálny roztokový sprej

jazz pharmaceuticals ireland ltd, Írsko - kanabinoidy - 63 - myorelaxantia